Document is current
Any future updates will be listed below
-
Authors
Yang, Jenny https://orcid.org/0000-0003-0352-8452
El-Bouri, Rasheed
O’Donoghue, Odhran
Lachapelle, Alexander S.
Soltan, Andrew A. S.
Eyre, David W.
Lu, Lei
Clifton, David A.
- License Information
-
More Information
Article History
Received: 12 January 2023
Revised: 15 August 2023
Accepted: 17 October 2023
First Online: 28 November 2023
Declarations
:
: DAC reports personal fees from Oxford University Innovation, personal fees from BioBeats, personal fees from Sensyne Health, outside the submitted work. DWE declares lecture fees from Gilead outside of the submitted work. No other authors report any conflicts of interest.
: United Kingdom National Health Service (NHS) approval via the national oversight/regulatory body, the Health Research Authority (HRA), has been granted for development and validation of artificial intelligence models to detect Covid-19 (CURIAL; NHS HRA IRAS ID: 281832). The eICU Collaborative Research Database (eICU-CRD) is a publicly-available, anonymized database with pre-existing institutional review board (IRB) approval. The database is released under the Health Insurance Portability and Accountability Act (HIPAA) safe harbor provision. The re-identification risk was certified as meeting safe harbor standards by Privacert (Cambridge, MA) (HIPAA Certification no. 1031219-2).
: NHS Health Research Authority approval was granted for the use of routine clinical and microbiology data from electronic health records (EHRs) for development and validation of artificial intelligence models to detect COVID-19 (CURIAL; IRAS ID 281832). As the study was limited to working with deidentified data collected within routine care, and extracted retrospectively, explicit patient consent for use of the data was deemed to not be required, and is covered within the HRA approval. All necessary consent has been obtained and the appropriate institutional forms have been archived.
: NHS Health Research Authority approval was granted for the use of routine clinical and microbiology data from electronic health records (EHRs) for development and validation of artificial intelligence models to detect COVID-19 (CURIAL; IRAS ID 281832). As the study was limited to working with deidentified data collected within routine care, and extracted retrospectively, explicit patient consent for use of the data was deemed to not be required, and is covered within the HRA approval. All necessary consent has been obtained and the appropriate institutional forms have been archived.
